A network analysis of COVID-19 mRNA vaccine patents
- 12 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 39 (5), 546-548
- https://doi.org/10.1038/s41587-021-00912-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Progress in Understanding and Treating SCN2A-Mediated DisordersTrends in Neurosciences, 2018
- Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disordersEpilepsia, 2018
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMNHuman Gene Therapy, 2018
- Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived NeuronsCell Reports, 2015
- Towards a therapy for Angelman syndrome by targeting a long non-coding RNANature, 2014
- The novel Cln1R151X mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapyHuman Molecular Genetics, 2014
- Boosting Pharmaceutical Innovation in the Post-TRIPS EraPublished by Edward Elgar Publishing ,2014
- Disruptive CHD8 Mutations Define a Subtype of Autism Early in DevelopmentCell, 2014
- Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNAImmunity, 2005
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990